BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Week in Review: Fosun Pharma And TPG Offer $369 Million For Chindex International, Inc. (CHDX)


2/24/2014 9:11:58 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

February 22, 2014 --Fosun Pharma and TPG, a US private equity company, teamed up to offer $369 million to take China hospital operator Chindex private; Harbin Gloria Pharma acquired Shanghai Huatuo Medical Science, a maker of TCM products, for $170 million; Tonghua Shuanglong Chemical paid $178 million to acquire Jinbao Pharma in a cash and stock deal; Citic Private Equity is reportedly seeking funds to buy Biosensors, a China cardiovascular device company that is worth $1.2 billion; Lee’s Pharma in-licensed China rights to tafoxiparin, a clinical-stage labor-inducing drug from Dilafor of Sweden; Solentim, a UK medical device maker, will market its CellMetric device in China through two China distribution companies; and Dr. Jonathan Wang discussed OrbiMed’s China investment strategies in an exclusive interview with ChinaBio® Today. More details….

Stock Symbols: (SHA: 600196; HK: 2196) (NSDQ: CHDX) (SHE: 002437) (SHE: 300108) (HK: 950)

Help employers find you! Check out all the jobs and post your resume.


Read at ChinaBio Today

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES